ISSCR_ID_MemberBriefings_Banner_1280x200_01

 

Member Briefings: ISSCR Guidelines Update

Join members of the task force charged with updating the ISSCR Guidelines for a four-part digital meeting series. Member Briefings: ISSCR Guidelines Update will address the 2021 Guidelines and recent advances in the field, including innovations in early embryo models, chimeras, organoids, genome editing, and the translation of stem cell research. During the briefings, attendees will have the opportunity to discuss the changes being considered by the task force. Available to ISSCR members only.

Program

Briefing 1: Embryo Models, Embryo Research, and the 14-Day Rule
10 November, 2020
16:30 - 18:00 EST (view your time zone)

The first briefing in the series will highlight the discussions around and recommendations on in vitro research with embryos including integrated and non-integrated stem cell-based embryo models and the culture of human embryos. The briefing will conclude with approximately 40 minutes for questions from attendees and discussion with the task force members.

Robin Lovell Badge Headshot
Robin Lovell-Badge, PhD
The Francis Crick Institute, UK
Janet Rossant Headshot
Janet Rossant, PhD
Gairdner Foundation/SickKids, Canada
Debra Mathews Headshot
Debra Mathews, PhD
Johns Hopkins University, USA

Briefing 2: Laboratory Research
11 November, 2020
16:00 - 17:30 EST (view your time zone)

The second briefing in the series will give an overview of the proposed changes to the categories of research and what type of research should and should not be reviewed and focus on specific areas of research involving chimeras and organoids. The briefing will conclude with approximately 40 minutes for questions from attendees and discussion with the task force members.

Robin Lovell Badge Headshot
Robin Lovell-Badge, PhD
The Francis Crick Institute, UK
Clark
Amander Clark, PhD
University of California, Los Angeles, USA
Insoo
Insoo Hyun, PhD
Case Western Reserve University School of Medicine, USA
Knoblich
Jürgen Knoblich, PhD
Institute of Molecular Biotechnology, Austria

Briefing 3: Genome Editing
18 November, 2020
16:00 - 17:30 EST (view your time zone)

The third briefing in the series will include presentations on new recommendations for preclinical and clinical research involving mitochondrial replacement techniques, somatic genome editing, and germline genome editing. The briefing will conclude with approximately 40 minutes for questions from attendees and discussion with the task force members.

Robin Lovell Badge Headshot
Robin Lovell-Badge, PhD
The Francis Crick Institute, UK
Charo
R. Alta Charo, JD
University of Wisconsin, USA
Andy Greenfield Headshot
Andy Greenfield, PhD
MRC Harwell Institute, UK
Naldini Luigi Headshot
Luigi Naldini, MD, PhD
Università Vita-Salute San Raffaele, Italy

Briefing 4: Clinical Translation and Regulatory Approval
19 November, 2020
16:00 - 17:30 EST (view your time zone)

The final briefing in the series will include presentations on the new recommendations for preclinical and clinical research and the regulatory authorization of stem cell-based therapeutics. It will also include a presentation on recommendations for curbing unproven therapies and preventing the premature commercialization of stem cell-based interventions. The briefing will conclude with approximately 40 minutes for questions from attendees and discussion with the task force members.

Robin Lovell Badge Headshot
Robin Lovell-Badge, PhD
The Francis Crick Institute, UK
Melissa Carpenter Headshot
Melissa Carpenter, PhD
ElevateBio/Carpenter Group Consulting, USA
Gail Naughton Headshot
Gail Naughton, PhD
Histogen, USA
Turner
Leigh Turner, PhD
University of Minnesota, USA